Involving end-users in software development is a goal envisioned by the Software Engineering community.
INTRODUCTION
The importance of the end-user involvement in software development has been a topic widely discussed in the academia (Ko et al., 2011; Fischer et al., 2004) . The role of end-user experts in any development process is essential, especially in complex domains as bioinformatics, where most of the domain knowledge is difficult to be translated by developers to a suitable implementation.
Domain-specific languages (Fowler, 2010) have been proposed as a solution to reduce the knowledge gap between end-users (or domain experts) and developers. According to Spinellis (Spinellis, 2001 ), some of their benefits are: 1) the concrete expression of domain knowledge; 2) the direct involvement of the domain expert in the software life cycle; and 3) the better expressiveness to describe domain implementations. According to Van Deursen et al. (Van Deursen et al., 2000) , DSLs can abstract the underlying software implementation as a set of domain concepts that endusers can easily understand. If an executable DSL is provided, end-users can use it to write their own programs.
Current DSL development methodologies (Strembeck and Zdun, 2009; Ceh et al., 2011) take into account end-users in requirements gathering and in deployment. Usually, developers create DSLs from a re- * Small and Medium Enterprise quirements specification without additional end-users participation. As a consequence, the discovery of any domain misunderstanding is delayed until a first version is delivered. This fact substantially increases the development time of the DSL if, for instance, the language editor or the execution environment must be reimplemented accordingly.
Agile Software Development ) and the Agile Manifesto (Beck et al., 2001 ) have praised for a set of good practices to improve software development. Among these practices, they have encouraged the involvement of end-users (or stakeholders) throughout the project, and the short delivery of prototypes for early error detection. We believe that some of these practices can be profitable in the context of DSL development.
The contributions of this research work are: 1) the identification of good practices from agile methods that apply in the DSL development context; and 2) the inclusion of these practices inside a DSL development process to improve end-user involvement.
Our DSL development process is based on the methodological guidelines proposed by Mernik et al. (Mernik et al., 2005) -to define the different process stages and activities-and the agile methods XP (Beck and Andres, 2004) , Scrum (Schwaber and Beedle, 2002) and Agile Modeling (Ambler, 2002) to analyse different agile practices. Briefly, the process is configured to create the DSL incrementally by means of small releases that satisfy a set of requirements. End-users participate in some activities during the development of each release-so they can provide constant feedback-and also evaluating the resulting DSL release implementation-so any detected error can be fixed in the next iteration.
In this paper we provide an overview of the process and we focus on the two first stages: Decision and Analysis. To illustrate both stages, we describe the development of a DSL for genetic disease diagnosis, which has been elaborated in close collaboration with experts from a bioinformatics SME. Due to the complexity of this evolving domain, this real scenario highlights the need of sound methodological practices to support a good communication with domain experts.
The rest of the paper is structured as follows. Section 2 reviews other approaches that research how to involve end-users or how to use agile practices in DSL development. Section 3 overviews the proposal: first, the methodological base for DSL development (proposed by (Mernik et al., 2005) ); second, the agile practices that apply in DSL context; and third, the agile DSL development process proposed. Section 4 and 5 describe in detail the Decision and Analysis stages, respectively, and several examples from a DSL for genetic disease diagnosis illustrate each stage. Section 6 discusses the main findings while applying the proposal. Finally, section 7 explains the conclusions and the future work.
RELATED WORK
Agility and end-user involvement in DSLs development have been previously addressed by the Software Engineering community.
On the one hand, several authors have addressed end-users involvement within software development processes.
The authors of (Pérez et al., 2011) propose a new method that encourages the analysis of end-users role in the development process. This approach takes into account good practices of end-user development, analyses user-requirements and develops the DSL accordingly. As a result, their method generates a visual domain-specific language by means of a tool. This approach adopts end-user development good practices to improve DSL development, which better satisfy user needs, with the aim to involve them afterwards in the future Model-Driven development process. On the contrary, our approach adopts good practices from agile methods to promote end-user involvement during the DSL development and to ensure their preferences are fulfilled within the DSL.
Also, the authors of (Izquierdo and Cabot, 2012 ) provide a collaborative infrastructure for their involvement in every stage of DSL development. Using their proposal end-users and developers interact until artefacts of each stage satisfy end-users' requirements. This approach supports an active involvement of end-users in all the stages of the development process. On the contrary, our approach promotes the use of agile practices as a way to make end-users involvement easier, but avoids their participation in the definition of artefacts outside their domain knowledge, such as conceptual models, which sometimes may be useless, if not detrimental.
On the other hand, several authors have addressed the application of agile principles on software development processes.
The authors of (Grigera et al., 2012) propose to bridge agile practices with model-driven development of Web applications by using Test-Driven Development. Starting with a set of user stories, authors propose the use of graphical user interface mockups for improving stakeholders involvement and requirements gathering. Authors also introduce a DSL, WebSpec, for specifying the interaction and navigation requirements. Following an agile iterative cycle and model-driven principles, a WebML model is derived that represents a Web application. Our approach shares some agile practices from this proposal, but it is mainly focused on DSL development instead of software generation from requirements.
Also, the work of (Visser, 2008) proposes the use of good practices from agile methods in DSLs development, such as carrying out the DSL development incrementally, addressing one concern at a time. This approach addresses the design and implementation of the DSL from abstractions obtained after analysing domain technologies, instead from a previous domain analysis. Likewise, our approach applies agile practices for DSL development and adopts an iterative cycle. However, our approach follows a deductive process (where a domain analysis is used in the design and this design is also used in the implementation) and promotes end-users involvement to improve their satisfaction about requirements coverage.
OVERVIEW OF AN AGILE DSL DEVELOPMENT PROCESS
Mernik et. al. discusses (Mernik et al., 2005) when and how to develop a DSL and provides a set of guidelines for future developers. The authors describe a development process made up of five stages: Deci-sion, Analysis, Design, Implementation and Deployment; and several patterns that aid developers in each of them. In a recent work (Ceh et al., 2011) , they have extended the process to seven stages adding Testing and Maintenance. This approach has been widely applied in different DSL development projects, for example (Jr. et al., 2011; Arora et al., 2009; Visser, 2008) . Because of these reasons, we have selected this work as a base of our proposal. Figure 1 (taken and adapted from (Ceh et al., 2011) ) depicts the stages-with the corresponding inputs and outputs-and the proposed patterns for the the first four stages: First, a Decision (1) is made about developing or not the DSL taking into account domain experts demands and the current state of the domain; If so, an Analysis (2) is performed,using different assets that represent the domain, to obtain a set of formal artefacts that represents the domain. Once the domain is clearly represented it is time to Design (3) the target DSL constructs; those designs are used to create an executable Implementation (4); which, in order to identify its correctness, is the subject of a Testing (5); if everything is correct, a Deployement (6) is carried out to be used by end-users and, optionally, a Maintenance (7) will perform any required change.
Agile methods have become widely popular for achieving end-user involvement and improving the time-to-market of software products (Beck et al., 2001) . Next, we explain the practices selected from XP, Scrum and Agile Modeling suitable for DSL development:
• Architectural Envisioning. This practice, proposed by the Agile Modeling approach, encourages the early identification of a viable technical strategy. Many times DSL development is guided by domain concepts, and how the DSL is going to be executable is decided in late stages. Because of that, sometimes is difficult to translate concepts to a working implementation, as some authors have stated (Visser, 2008) . Applying this practice, developers can select and adapt domain concepts according to the DSL execution environment expected.
• User Stories. In order to manage requirements in agile methods, they are divided in user stories, which are brief descriptions related by end-users about a demand that contributes to add value. The set of user stories provides a simplified view of the functional features to be developed. In the context of DSL development, user stories are an effective instrument to discover the language constructs and concepts to be introduced in the DSL. Hence, user stories guide the development and provide traceability between initial requirements and the final DSL constructs. Also, user stories are useful to aid end-users to establish their priorities about the requirements to be introduced into the DSL.
• Acceptance Tests or Usage Scenarios. In order to check the fulfilment of requirements in agile methods, end-users briefly describe scenarios that must be accomplished by the software to be developed. In DSL development such scenarios are interesting not only for testing purposes but also for improving the understanding about the domain. In our approach, acceptance tests are the primary validation source to ensure that the DSL satisfies end-users' expectations.
• Iteration Planning or Sprint. The majority of agile methods manage the development in a set of iterations in which only a small set of features is implemented. This practice encourages faster re-leases that can be evaluated by stakeholders, or end-users in our context. DSL development can benefit from this practice by checking if the concepts required by end-users are included in incremental subsets of the DSL. Also, errors can be detected without developing the complete DSL infrastructure (editor, execution environment, etc.).
• Incremental Design. Together with a development based on iterations, agile practices promote the incremental design of the software (models, UI, components, etc.). Many DSL development approaches design the whole abstract language from a previous domain analysis. The design of a full DSL is a time-consuming task and it is not finished until end-users evaluate the result. We believe that if DSL developers and end-users are focused on an small set of constructs or user stories, DSL can be built more easily and it is more flexible to changes. Our work proposes an agile DSL development process that combines the aforementioned methodological guidelines with the chosen agile practices, to provide faster small releases of the DSL and to involve end-users. Figure 2 overviews the proposal. The most relevant feature of the process is the inclusion of an iterative cycle for the stages Analysis, Design, Implementation and Testing. The stages Deployment and Maintenance have been avoided for simplification purposes.
In the Decision stage all decision patternsNotation, AVOPT, Task automation, Product line, Data structure representation, Data structure traversal, System front-end, Interaction and GUI construction from Mernik et. al guidelines-are adopted to decide if developing the DSL is worth. End-users provide information about existing tools and about their requirements. Following the agile practice architectural envisioning, we propose to make a deeper use of this information to elaborate a review (1) where available technology such as DSLs, software tools, frameworks, etc., are assessed regarding end-users' requirements. This review is useful to better justify the decision to develop the DSL and, eventually, to make early decisions about the architecture and the implementation platform.
After this stage, following the agile practices iteration planing and incremental design, the original sequential process, which includes Analysis, Design, Implementation and Testing, is transformed into an iterative process. Decision Stage remains outside because the decision to design the DSL is only made once.
The proposed iterative cycle gathers: • Analysis Stage. Following the agile practices user stories, acceptance tests and iteration planning, this stage is extended with two steps:
-Requirements Specification (2). This step refines the preliminary requirements specification detailing all requirements expected for a complete DSL. To comply with agile practices, enduser's requirements are divided in a set of user stories (2a) and acceptance tests (2b), in a similar way than XP and Scrum. -Iteration Planning (3). This step completes the specified user stories with their priorities and settles a list (or sprint backlog using the Scrum terminology) that defines their implementation order according to end-users' preferences. In order to optimize the iterative cycle, in each iteration a set of user stories are chosen to be implemented, instead of addressing one user story per iteration. An agreed release deadline is scheduled and an acceptance test (3a) that covers all these user stories is defined. -Domain Analysis (4). This step follows the informal pattern from Mernik et al. guidelines to create a set of artefacts that precisely describe the DSL domain. We choose this pattern as a way to avoid the overloading that carrying out a complete formal method may introduce. We adopt the definition of a feature model (4a) (firstly introduced by (Kang et al., 1990) ) to express the variabilities and commonalities of the DSL, and the definition of a conceptual model (4b) (a UML Class Diagram) to precisely describe the terminology, the concepts involved in the DSL and the relations among them. To comply with the agile practice incremental design, these artefacts are created incrementally, so they represent only the sub-domain related with the selected user stories of the current iteration (and the previous ones).
Due to end-users are more interested in talking about their domain problems than working in software development issues that address them (Fischer et al., 2009), we have promoted their participation in steps directly related with such problems: In the Requirements Specification step they explain their requirements and tests to be satisfied, and in the Iteration Planning step they point out their priorities and specify a scenario that gathers several user stories. On the contrary, their involvement in the development of feature and class models is avoided. In our experience, end-users are not comfortable with this kind of models, and the lack of understanding could create mistakes (Costabile et al., 2008) . • Design Stage (5). Following the agile practice incremental design, the syntax and semantics designs represent only the user stories of the current iteration (and the previous ones). As an optional step, end-users can express their preferences about the end-user oriented (concrete) syntax (5a), which normally is a visual projection of the core (concrete) textual syntax. Additionally, developers validate that the Abstract syntax can be instantiated to support all acceptance tests specified in the Analysis stage (5b).
• Implementation Stage (6). Following the agile practices incremental design and architectural envisioning, the DSL is implemented taking into account the partial syntax and semantics from the Design stage and the technological review performed in the Decision stage. As a result, a prototype (6a) DSL that complies with the set of user stories (from this iteration and the previous ones) is created (or evolved from previous iterations). End-users are not involved in this stage.
• Testing Stage (7): In this stage the prototypical implementation is tested against the requirements from the current iteration. First, the specified acceptance tests are checked. And then, the prototype is shown to end-users so they check the acceptance tests and provide their opinion (7a): agreeing with the functionality they expected and rejecting the functionality they don't like. Additionally, end-users can provide insights about new requirements they are interested in. 
DECISION STAGE
In this section, we apply the Decision stage of our proposal to develop a DSL for customizing genetic disease diagnosis software. First, we explain a real scenario in the genetics domain where geneticists face a set of problems related with end-user software development. As a solution, we propose the development of a DSL and we explain how it fits to solve their problems. Second, we provide a preliminary description of geneticists' requirements, a review about technologies for the development of genetic disease diagnosis software and the suitable decision patterns that apply within the context of the DSL.
Genetic Disease Diagnoses
In the genetics domain, DNA structures and their relationships with human traits are too difficult and heterogeneous to be understood by people outside the domain. For this reason, geneticists with some programming knowledge have been traditionally developing their own databases, analysis algorithms, scripts, frameworks and development tool-kits over the years. Even so, as not every geneticist is experienced in software development, they create scientific workflows to reuse available software applications. Unfortunately, these software applications are often created to fulfil specific requirements rather than being designed for reuse. Customization and data exchange, if possible, often requires advanced programming skills that geneticists don't usually have.
A common scenario to face this problem is that geneticists create spread sheets to perform data operations and copy results into text files themselves to exchange data among different applications. This situation highly impacts on their productivity, and it has become even more critical since the recent improvements in sequencing technologies, which now produce more genetic data than experts are able to analyse (Rusk, 2009 ).
An example of this situation is in IMEGEN (IMEGEN, ), a bioinformatics SME working on the diagnosis of genetic diseases. In order to understand its context, Figure 3 overviews its process for genetic disease diagnosis:
1. Patient's Variation Gathering Phase: A patient's DNA sample is inspected with a software tool (chosen according to the diagnosis technique performed) to obtain a report of genetic variations. The term variation is used to express how the content of the patient's DNA in a specific position is different from the content of a "disease-free" DNA reference sequence in the same position.
2. Disease Knowledge Phase: Each variation detected in the previous phase is searched in different databases and websites until success. If a variation has been previously described, additional information related to a genetic disease is retrieved.
If not, it is characterized as an unknown variation.
3. Report Generation Phase: All genetic variations and their associated information are gathered in a report according to geneticists' preferences. To do this, they use a spread sheet or a word-document template to represent all the information.
If the analysis outcome is only a single gene, geneticists from IMEGEN are able to perform this pro- cess manually: interacting with different tools and searching information through different databases. However, when they must manage bigger amounts of genetic data and take into account a wider array of knowledge resources (websites, databases, scientific papers, etc.), their current procedure is no longer feasible.
Geneticists from IMEGEN need to create their own software applications that support different genetic disease diagnoses, but the software mechanisms to do it must avoid programming issues and hide technological details. In this context, a DSL is a good choice to provide such mechanisms.
Working with IMEGEN, we have realized that the genetic disease diagnoses observed share the same process, but also, each disease diagnosis introduces slight variations. For example, both Medullary Thyroid Cancer and Achondroplasia diagnoses require identifying genetic variations that geneticists associate with the target disease. However, the Cancer is analysed with a technology that provides the patient's sequence in SEQ format, while the technology for the Achondroplasia provides the patient's variations in VCF format. Once obtained the variations, for the cancer, only the exons (regions) 10 and 11 from the gene RET are validated with different databases while for the Achondroplasia, locating the variations "p.Gly380Arg" or "p.Gly375Cys" in the gene FGFR3 is enough to confirm the disease. All these commonalities and variabilities that are directly related with the genetics domain are well understood by geneticists so they are perfect candidates to become constructs of the DSL.
In summary, geneticists can be provided with a "programming language" for specifying genetic disease diagnoses. This new language will provide abstractions at the genetic domain knowledge level, that is, related to genetic concerns that geneticists under-stand, in order to manage the underlying technological implementation.
A DSL for Customizing Genetic Disease Diagnosis Software
With this goal in mind, we address the definition of a DSL to compose and customize genetic disease diagnosis software. The DSL will support monogenic and multigenic disease diagnoses. At the moment, among all kinds of diseases, the DSL addresses the ones where a cause-effect relation can be established between a genetic variation and a disease (an example list can be downloaded from http://www.imegen.es/cms_genetic_diagnosis.php). A brief summary of the requirements they expect to create a customized tool are:
• R1. Retrieve all variations from a patient once its sample has been analysed chemically: because there are different techniques and technologies that use different outputs, this requirement is decomposed in three:
-R1.1 Get variations from a file that contains the patient's sequence data. -R1.2 Get variations from a file that contains the alignment between the patient's sequence and a reference sequence. -R1.3 Get variations from a file that contains the patient's variations.
• R2. Search the patient's variations in different genetic databases: each analysis will require a different set of genetic databases, sometimes databases that gather knowledge from different diseases and others disease-specific databases.
• R3. Filter the list of patient's variations for a specific region or look for a set of interesting variations: when a disease is being diagnosed not every variation is always relevant.
• R4. Gather in a report only the essential information for the target disease: using their expertise, geneticists choose the meaningful variations and the proper knowledge related with them. Now, end users enumerate the tools they know in their domain to "create" themselves their own software applications. Following our approach, we review these tools to evaluate the support of the named requirements. Our goals are to assess if the current state of the domain technology satisfies geneticists' expectations, to detect if a DSL is useful in the domain, and to identify what could be reused for its implementation environment. Some examples of these tools are: Biojava (version 3.0.5) (Holland et al., 2008) , Taverna (version 2.4) (Hull et al., 2006) , Galaxy (online version) (Goecks et al., 2010) and Alamut (version 2.2) (Alamut, ). Table 1 summarizes the coverage of the aforementioned requirements by the suggested tools.
Biojava is a framework, based on the Java language, composed by a set of programming libraries to create Java programs for analysing genetic data. Biojava supports the reading of several file formats and the execution of analysis algorithms; however, in order to combined them to identify the patient's variations, geneticists should have Java programming skills. The rest of requirements are not supported.
Taverna is a desktop tool for the design, edition and execution of workflows based on the integration of web services specially focused on the biological domain. It allows retrieving data from databases that comply with Biomart technology (Haider et al., 2009) , and saving results in XML or XLS format. However, some programming knowledge is required to search variations inside the data obtained by retrieval services and to filter them. It does not support to identify variations from patient's data.
Galaxy is a web environment that integrates a set of genetic services and allows running those services independently or creating workflows combining them. It integrates services that combined, eventually, are able to identify variations from alignments or import a list of variations, retrieve data from a set of genetic databases and filter the obtained data sets. However, it requires a deeper knowledge of Galaxy structure and programming knowledge to identify variations from patient's sequence data and search patient's variations in genetic databases. It does not support to create customized reports.
Alamut is a desktop tool that provides a userfriendly interface for the interpretation of genetic variations. Variations can be retrieved by reading a file that contains a list or adding them, one by one, manually. Once in the system, variations can be searched into a set of predefined genetic databases. However, in order to create customized reports users must program templates and perform post processing operations. It is not possible to read variations from the patient's sequence or alignments, neither to filter variations.
This technological review envisions the need for more streamlined and easier to use software customization mechanisms, because although almost all requirements can be satisfied by the analysed tools, geneticists are forced to learn a programming language and deal with technological details (XML configuration files, workflow design, database connections, etc.) to fully accomplish their necessities. Mostly, they are reluctant to learn a new technology because they are not sure if the time invested is worth.
A DSL will hide these low-level details and its technological implementation will integrate some functionalities of these tools under higher level constructs related with diagnosis concerns. For example, from the reviewed tools it can be reused: 1) file readers from Biojava; 2) genetic data retrieval mechanisms from Taverna, Galaxy or Alamut; 3) filters from Galaxy; and 4) file writers from Taverna or Alamut.
After the technological review of bioinformatic tools, we go on with the decision. Among all decision patterns adopted from the original methodology, we consider that the following ones justify the decision to proceed with the DSL development:
1. Task Automation. The DSL can automate a set of activities that geneticists are performing manually. For example, nowadays geneticists are responsible for the interoperability among software applications, a difficult task due to the wide array of genetic data formats available. Thus, a set of DSL constructs will manage the format interoperability among different software artefacts.
2. Product Line. The DSL can be used to configure highly similar genetic disease diagnoses that conform to the general process. Geneticists will express the specific properties depending of the disease and the diagnosis approach.
3. Interaction. The DSL can hide technological details that are outside the scope of geneticists' knowledge. For example, geneticists are responsible to discern the most suitable DNA alignment algorithm from a wide array of choices. This should be decided using genetic and diagnosis features instead of algorithm-related implementations. For example, geneticists should choose between "protein alignment" and "nucleotide alignment" instead of between "blastp" (blast algorithm for proteins) and "blastn" (blast algorithm for nucleotides) algorithms.
4. GUI Construction. The DSL can be used to customize how geneticists interact with data. They will be able to describe their own interfaces by indicating the inputs they want to provide to the diagnosis and the reports to be generated.
ANALYSIS STAGE
In this section, we apply the Analysis stage of our proposal to develop a DSL for customizing genetic disease diagnosis software. We explain the Requirements Specification, Iteration Planning and Domain Analysis steps of the first iteration and provide a set of examples.
Requirements Specification
In this step, the preliminary requirements specification is extended with the elaboration of user stories and acceptance tests.
As we have discussed in Section 3, user stories and acceptance tests are the agile practices selected for requirements specification. In order to describe user stories, agile methods encourage the use of few sentences written by end-users avoiding the use of difficult technical syntax. These sentences usually describe the users role, the action to be accomplished and the goal they pursue. A set of examples from our DSL for are:
1. User story 1 (associated with requirement R1.1):
"I want choose a file with SEQ format from the computer, so that the patient's sequence is read".
2. User story 2 (associated with requirement R1.1): "I want choose a reference sequence from the computer, so that it can be used afterwards to perform comparisons".
3. User story 3 (associated with requirement R1.1): "I want to get a reference sequence from the NCBI database by indicating its RefSeq identifier, so that it can be used afterwards to perform comparisons".
4. User story 4 (associated with requirement R1.1): "I want to align a patient sequence against a reference sequence, so that I can see how they match".
5. User story 5 (associated with requirement R1.3): "I want to choose a file with VCF format from the computer, so that the patient's variations are read".
6. User story 6 (associated with requirement R2):"I want to search the variations against the dbSNP database, so that patient's variations that are SNPs can be identified".
7. User story 7 (associated with requirement R3): "I want to indicate a list of variations in HGVS_Protein notation, so that only those variations are taken into account". For each user story, several acceptance tests are defined. An acceptance test is a description of usage (real inputs and expected outputs) of a user story that is defined with the aim to check the correctness of its implementation. When a user story is delivered, it can only be considered complete after it has passed all its acceptance tests. These tests are different from unit tests because they check the functionality taking into account end-user's experience, nor the expected behaviour of internal implementation details. In order to describe them, it is encouraged the same guidelines than user stories, to use of few sentences written by end-users that describe the user role, the action they will be performed within the system and the response they expect. The acceptance tests related with the user story 5 are: 1. Acceptance Test 5.1: "I will choose the file 3Variations.vcf to check that the three variations {g.1234A>C, g.4567C>G, g.8910insAA} are read".
2. Acceptance Test 5.2: "I will choose the file Empty.vcf and I expect to get an error that says that the file is empty".
3. Acceptance Test 5.4 "I will choose the file NoReference.vcf and I expect to get an error that says that the reference has not been indicated".
4. Acceptance Test 5.3: "I will choose the file Variations.sam and I expect to get an error that says that the file has the wrong format". The major effort invested by end-users in this step is performed in the first iteration. In the following iterations, end-users will refine those user stories and acceptance test that, for any reason, were incorrect or unambiguous, remove the ones that are not required anymore and include the new ones.
Iteration Planning
In this step, end-users prioritize user stories and choose the ones that are implemented in the current iteration. In each iteration, end-users define one or more acceptance test that gather several user stories. These acceptance tests, which we name scenarios, are different from previous acceptance tests because they are designed to check user stories correctness working as a unit. An scenario is a reflection for end-users about what they will be able to accomplish with the prototypical implementation at the end of the iteration.
In our example, in the first iteration, end-users together with developers have established that the most important user stories are the number 5 and 7 because: 1) they are the most easier and simpler to be translated into a DSL; and 2) they provide a remarkable improvement over their current practices. An example of scenario that gathers both user stories is:
Scenario 1: "To diagnose the Achrondoplasia Disease, I will chose the file "variations.vcf" (which I obtained from my sequencing machine in the VCF format) to see if the patient has the variations p.Gly375Cys and p.Gly380Arg"
This acceptance test reflects what geneticists expect to accomplish at the end of the first iteration: 1) To provide a VCF file that is saved in their computer (user story 5); 2) to see the variations once the file is selected (user story 5); 3) to provide a list of expressions in HGVS_Protein notation (user story 7); and 4) to see only the variations that match in their HGVS_Protein notation with any of the expressions provided (user story 7).
Domain Analysis
The goal of this step is to represent unambiguously the domain of the DSL. Our process adopts the informal pattern proposed by the original methodology and proposes the definition of a feature model and a conceptual model (as explained in section 3).
According to the agile practice incremental design, the domain to be represented by both models corresponds only to the set of user stories addressed in the current iteration. Because both models are incrementally created in each iteration, this step adds new elements, such as attributes or relationships, or refines the existing ones.
Following with our example, the models that represent the user stories 5 and 7 are:
• The Feature Model (Figure 4 ) has as a root feature Genetic Diagnosis, which represents the type of applications that can be expressed using the DSL. Taking into account the addressed user stories, these applications gather two capabilities, which are represented in the model as two branches:
Represents the information of a patient analysed to diagnose a genetic disease. In the current iteration, the only kind of patient's data is a set of Variations expressed in the VCF format. This branch represents the capabilities related to the user story 5. -Variation Analysis (right branch): Represents the activities to be performed in order to identify any evidence of a disease in a patient. In the current iteration, this analysis consists of applying a Filter over the list of patient's Variations. The filter criteria is expressed using the HGVS_Protein notation. This branch represents the features related to the user story 7.
We must remark that all features explained in this model are mandatory because in this first iteration user stories do not describe any alternative feature. It is expected that next iterations will provide new features that will reveal: new branches, optional features, or new choices under a feature. For example, there is a user story that requires filtering the variations using the HGVS_Coding notation. To represent this user story, a new child of Filter will be defined and the mandatory property of HGVS_Protein will be changed for a choice between the two notations.
• The Conceptual Model ( Figure 5 ) gathers the main concepts involved in genetic disease diagnoses: Disease, Patient and Variation:
-The entity Patient represents a human being that has taken a genetic test to find out if he or she is genetically predisposed to get a certain disease. It has an attribute id that identifies a patient from others. This entity represents a concept of the user story 5. -The entity Variation describes the content of the patient's DNA in a specific position or region, but it is called variation because it is expressed in regards of a reference DNA. To perform the diagnosis, geneticists are interested in the Variations that a Patient has, represented by a composition association between both entities. The attribute HGVS_ProteinNotation is a notation created by the genetics community to express unambiguously what is occurring in the patient at the protein level (which protein should be created and which one is being created by the patient). The entity and the relationship repre- sent the concepts involved in the user story 5, and the attribute HGVS_ProteinNotation represents a concept involved in the user story 7. -The entity (Genetic) Disease is a condition related with the DNA chemicals that causes a body malfunction. The attribute name identifies the disease inside the medical community. A diagnose is made when it is found a relationship between a patient's Variation and a Disease, which predisposes the patient to get the disease. This relationship is made thanks to geneticists knowledge about the disease. The entity, attribute and association represent the concepts involved in the user story 7.
DISCUSSION
After applying the two first stages described to develop a DSL for a bioinformatics SME, we have found that combining methodological guidelines for DSL development with agile practices improves enduser involvement in several ways. This feedback has been gathered in the meetings with two geneticists, three bioinformaticians and two developers-while carrying out the Decision stage and the Analysis stage of the first iteration of the process. First, end-users are able to understand the artefacts which they are required to interact and contribute. For example, they use their own words to specify user stories and acceptance tests. This fact is important because a good communication between end-users and DSL developers reduces misunderstanding about endusers' requirements and aids in the detection of errors.
Second, end-users are able to lead the process and make decisions. The ongoing process can be adapted to their immediate necessities because they are responsible to decide which user stories must be accomplished in each iteration. This situation encourages end-users to actively participate because they feel relevant for the DSL development.
Additionally, we have found that end-users acquire a better knowledge of the current state of the DSL development process. As they participate in the creation of the iteration planning, they are aware about what user stories have been already accomplished, what is being addressed and when user stories are planned to be finished. This situation improves the relationship between end-users and developers: endusers know exactly what to expect from developers and they do not create themselves false expectations that lead to future disappointments.
We should remark that these facts are not thoroughly validated as we have detected them during the first iteration planning. In future work, we plan to carry out more iterations to support these findings and also to asses the complete process. For example, asking end-users about their opinions regarding the difficulties found, the time they invested and the support to react against their changing needs.
In summary, the benefits observed up now show promising results of the use of good practices from agile methods in DSL development to involve endusers.
CONCLUSIONS
This research work proposes an agile DSL development process that adopts a set of practices from agile methods, with the main goal of improving end-users involvement in DSL development. The agile practices included are: 1) an iterative cycle, which addresses only a set of end-users' requests each iteration; 2) a requirements specification activity based on the specification of user stories and acceptance tests, which ensures that end-users communicate their ongoing requirements in each iteration; and 3) an iteration planning step based on priorities and scenarios, which ensures that end-users express their ongoing priorities and expectations. Thanks to these agile practices, a better involvement of end-users in DSLs development is expected as the preliminary results show.
We must remark that end-users involvement supposes an overloading for some of them: they do not appreciate the direct benefits or they are only interested in the finished DSL.This fact highlights the necessity of an agile DSL development process, which is our main goal.
As future work, we will detail the stages not included in this paper: Decision, Implementation and Testing. Our goal is to clearly define each stage, selecting the agile practices that improve end-user involvement. Simultaneously, we will continue with the development of the DSL for genetic disease diagnosis in order to observe the practical benefits. Additionally, geneticists from the SME will test the final DSL with different disease diagnosis in order to assess the completeness of the DSL developed.
